BGM0504 tablets

DRUG3 trials

Sponsors

BrightGene Bio-Medical Technology Co., Ltd.

Conditions

Chinese Healthy VolunteersHealthyNon-diabetic Overweight or ObeseOverweight or Obese Participants Without Diabetes

Phase 1

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

RecruitingNCT07239973

BrightGene Bio-Medical Technology Co., Ltd.Healthy, Non-diabetic Overweight or Obese

Start: 2025-10-21End: 2026-03-31Target: 75Updated: 2025-11-20

A Study of BGM0504 Tablets in Healthy Chinese Subjects

RecruitingNCT07566572

BrightGene Bio-Medical Technology Co., Ltd.Chinese Healthy Volunteers

Start: 2026-03-26End: 2026-09-30Target: 144Updated: 2026-05-05

Phase 2

A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

Not yet recruitingNCT07658560

BrightGene Bio-Medical Technology Co., Ltd.Overweight or Obese Participants Without Diabetes

Start: 2026-06-30End: 2027-02-28Target: 200Updated: 2026-06-22